Pesquisas alternativas:
chimp dan » chimp can (Expandir a Pesquisa), shimp dawn (Expandir a Pesquisa)
dan non » than non (Expandir a Pesquisa), dan ning (Expandir a Pesquisa)
5 nail » _ nail (Expandir a Pesquisa), a nail (Expandir a Pesquisa)
3 nail » _ nail (Expandir a Pesquisa), a nail (Expandir a Pesquisa), 3 nacl (Expandir a Pesquisa)
i hiv » ii hiv (Expandir a Pesquisa), 1 hiv (Expandir a Pesquisa), a hiv (Expandir a Pesquisa)
chimp dan » chimp can (Expandir a Pesquisa), shimp dawn (Expandir a Pesquisa)
dan non » than non (Expandir a Pesquisa), dan ning (Expandir a Pesquisa)
5 nail » _ nail (Expandir a Pesquisa), a nail (Expandir a Pesquisa)
3 nail » _ nail (Expandir a Pesquisa), a nail (Expandir a Pesquisa), 3 nacl (Expandir a Pesquisa)
i hiv » ii hiv (Expandir a Pesquisa), 1 hiv (Expandir a Pesquisa), a hiv (Expandir a Pesquisa)
1
“... polymorphism. To assess whether viruses exploit this apparent vulnerability, we study the evolution of HIV-1...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Yusim, Karina, Kesmir, Can, Gaschen, Brian, Addo, Marylyn M., Altfeld, Marcus, Brunak, Søren, Chigaev, Alexandre, Detours, Vincent, Korber, Bette T.
Publicado em 2002
“... responses to five HIV-1 proteins, Gag p17, Gag p24, reverse transcriptase (RT), Env, and Nef, have been...”Publicado em 2002
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
“... these interactions can reveal new targets for therapeutic interactions against HIV-1....”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Takahashi, Mayumi, Li, Haitang, Zhou, Jiehua, Chomchan, Pritsana, Aishwarya, Veenu, Damha, Masad J., Rossi, John J.
Publicado no Mol Ther Nucleic Acids (2019)
“... ASOs can be attributed to RNase H1 activation and steric hindrance of dimerization. Using 5′-RACE PCR...”Publicado no Mol Ther Nucleic Acids (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
“... antibodies broadly neutralizing and new T cell vaccine approaches can overcome virus variability....”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Arts Eric J
Publicado em 2012-10-01
“...<p>Abstract</p> <p>Approximately 20 years has passed since the first human trial with HIV-1...”Publicado em 2012-10-01
Obter o texto integral
Artigo
7
Por Arts, Eric J
Publicado em 2012
“...Approximately 20 years has passed since the first human trial with HIV-1 protease inhibitors...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Bilenoğlu, Onur, Altındiş, Mustafa, Öz, Ersoy, Yücel-Öz, Yeliz, İrigül-Sönmez, Öykü, Ünal, Can Bora
Publicado no Bosn J Basic Med Sci (2015)
“... immunocompromised patients, like transplant recipients or HIV-infected individuals. Early diagnosis...”Publicado no Bosn J Basic Med Sci (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Churchill, Melissa J., Cowley, Daniel J., Wesselingh, Steve L., Gorry, Paul R., Gray, Lachlan R.
Publicado no J Neurovirol (2014)
“... and does not give rise to new viral particles. The major barrier to the elimination of HIV-1...”Publicado no J Neurovirol (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
“.... APOBEC3G (A3G) and APOBEC3F (A3F) are host cell DNA-editing enzymes that induce extensive HIV-1 mutation...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
“...Harlem Hospital in New York City has one of the highest HIV-1 newborn seroprevalence rates...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
13
Por Pritchard, Laura K., Harvey, David J., Bonomelli, Camille, Crispin, Max, Doores, Katie J.
Publicado no J Virol (2015)
“...The gp120/gp41 HIV-1 envelope glycoprotein (Env) is highly glycosylated, with up to 50% of its mass...”Publicado no J Virol (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
15
Por Sanchez-Merino, V., Fabra-Garcia, A., Gonzalez, N., Nicolas, D., Merino-Mansilla, A., Manzardo, C., Ambrosioni, J., Schultz, A., Meyerhans, A., Mascola, J. R., Gatell, J. M., Alcami, J., Miro, J. M., Yuste, E.
Publicado no J Virol (2016)
“... rare, can be induced much earlier than previously thought. The identification of HIV-1-infected...”Publicado no J Virol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
“...PURPOSE OF REVIEW: Studies of HIV-1 genetic diversity can provide clues on the effect...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
“... for controlling HIV-1 replication. Another type of therapeutic nucleic acid – aptamers – shows promise as a new...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Ako-Adjei, Danso, Fu, William, Wallin, Craig, Katz, Kenneth S., Song, Guangfeng, Darji, Dakshesh, Brister, J. Rodney, Ptak, Roger G., Pruitt, Kim D.
Publicado no Nucleic Acids Res (2014)
“... targets. Each HIV-1 human protein interaction can be retrieved without restriction by web-based downloads...”Publicado no Nucleic Acids Res (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
“... drugs. While combinatorial antiretroviral therapy (cART) can potently suppress HIV-1 replication...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Chertov, Oleg, Zhang, Ning, Chen, Xin, Oppenheim, Joost J., Lubkowski, Jacek, McGrath, Connor, Sowder, Raymond C., Crise, Bruce J., Malyguine, Anatoli, Kutzler, Michele A., Steele, Amber D., Henderson, Earl E., Rogers, Thomas J.
Publicado em 2011
“... for the design of new inhibitors of HIV-1....”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo